Furazolidone
- Generic Name
- Furazolidone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C8H7N3O5
- CAS Number
- 67-45-8
- Unique Ingredient Identifier
- 5J9CPU3RE0
- Background
A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone binds bacterial DNA which leads to the gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
- Indication
For the specific and symptomatic treatment of bacterial or protozoal diarrhea and enteritis caused by susceptible organisms.
- Associated Conditions
- Diarrhea (Dysentery), Infectious diarrhea
- Associated Therapies
- -
Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
- First Posted Date
- 2023-12-13
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Yongquan Shi
- Target Recruit Count
- 688
- Registration Number
- NCT06168084
- Locations
- 🇨🇳
Xijing Hosipital of Digestive Disease, Xi'an, Shanxi, China
Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
- Conditions
- Interventions
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-05-15
- Target Recruit Count
- 855
- Registration Number
- NCT05718609
- Locations
- 🇨🇳
Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China
Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin
- First Posted Date
- 2021-11-26
- Last Posted Date
- 2021-11-30
- Lead Sponsor
- Shandong University
- Target Recruit Count
- 170
- Registration Number
- NCT05135182
- Locations
- 🇨🇳
Qilu hosipital, Jinan, Shandong, China
Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication
- First Posted Date
- 2021-06-01
- Last Posted Date
- 2021-06-01
- Target Recruit Count
- 234
- Registration Number
- NCT04907747
- Locations
- 🇨🇳
Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China
Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
- First Posted Date
- 2020-12-22
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- Xijing Hospital of Digestive Diseases
- Target Recruit Count
- 658
- Registration Number
- NCT04678492
- Locations
- 🇨🇳
Xijing Hosipital of Digestive Disease, Xi'an, Shaanxi, China
Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin
- First Posted Date
- 2020-02-11
- Last Posted Date
- 2021-11-18
- Lead Sponsor
- Shandong University
- Target Recruit Count
- 250
- Registration Number
- NCT04264663
- Locations
- 🇨🇳
Qilu hospital, Jinan, Shandong, China
A Comparison of Clarithromycin-based and Furazolidone-based Bismuth-containing Regimens for H. Pylori Eradication
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2020-06-23
- Lead Sponsor
- Shandong University
- Target Recruit Count
- 350
- Registration Number
- NCT03716622
- Locations
- 🇨🇳
Qilu hosipital, Jinan, Shandong, China
Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2019-08-30
- Lead Sponsor
- Xijing Hospital of Digestive Diseases
- Target Recruit Count
- 658
- Registration Number
- NCT03609892
- Locations
- 🇨🇳
Xijing Hosipital of Digestive Disease, Xi'an, Shaanxi, China
Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
- First Posted Date
- 2017-05-03
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- Yanqing Li
- Target Recruit Count
- 120
- Registration Number
- NCT03139253
Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy
- First Posted Date
- 2016-09-09
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT02894268
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital,Zhejiang University, Hangzhou, Zhejiang, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.